Steroids for mild heart inflammation with weaker pumping
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether a course of steroid medicine can improve outcomes in people with recently started myocarditis (heart muscle inflammation) and mildly reduced heart pumping. It compares steroids versus placebo (inactive treatment) to see if steroids help the heart recover and prevent worsening.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your heart ultrasound shows mildly reduced pumping (LVEF under 50%)
- Your ultrasound also meets a heart size limit (LV end-diastolic diameter under 56 mm)
- Blood tests show heart injury (troponin about three times higher than normal)
- Your heart symptoms started within the last 3 weeks
- You can be randomized within 120 hours (5 days) after hospital admission
- You do not have certain excluded causes of heart injury (for example, blocked heart arteries for people age 46+ after checking)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if corticosteroids (steroids) help people with acute myocarditis, a sudden inflammation of the heart muscle. It aims to improve heart function and reduce symptoms like chest pain or heart failure.
This trial tests whether colchicine (a medicine that reduces inflammation) improves outcomes in people with acute myocarditis soon after symptoms start. Half of participants get colchicine and half get a placebo to see which works better.
This study tests whether steroid medicine helps people hospitalized with suspected acute myocarditis (inflammation of the heart). Participants are randomly assigned to receive steroids or a placebo, and the trial looks at outcomes after the acute episode starts.
This trial tests if high-dose steroids and/or immunoglobulins (antibody treatments) help people with sudden, severe heart inflammation (fulminant myocarditis) that causes shock or dangerous heart rhythms. The goal is to see which treatment or combination reduces heart damage and improves recovery.
This study compares two treatment strategies for people with unexplained heart failure and irregular heartbeats caused by inflammation: one group gets standard heart medications plus an immune-suppressing steroid (prednisone), and the other gets standard medications alone. Doctors want to see whether adding steroids helps improve heart function and control dangerous heart rhythms.
This study tests whether giving a high dose of a steroid medication (glucocorticoid) early, before reaching the hospital, can help people having a severe type of heart attack called STEMI. If you are having this specific heart attack and meet the criteria, receiving this medication might improve your recovery.
Hear when a new Acute Myocarditis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.